期刊
BIOMARKERS
卷 14, 期 4, 页码 213-218出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13547500902818246
关键词
Bacillus Calmette-Guerin; urothelial bladder cancer; haplotype; polymorphism
资金
- Department of Science and Technology New Delhi, India
- Department of Biotechnology, New Delhi India
The association of interleukin-1 beta (IL-1 beta) -511C>T and IL-1 receptor antagonist (IL-1RN) VNTR, transforming growth factor-beta (TGF-B1) +28C>T and interferon-gamma (IFN-G)+874T>A polymorphisms with bladder cancer (CaB) susceptibility and risk of recurrence in Bacillus Calmette-Guerin (BCG)-treated patients was analyzed in 287 controls and 213 CaB patients (73 BCG treated). Increased risk was observed with the IL-1RN*2 allele (odds ratio (OR) 5.01) and the IFN-G +874 A allele (OR 1.78). TGF-BTT and IFN-G +874 A carriers were associated with reduced (hazard ratio (HR) 0.37) and enhanced (HR 2.24) risk of recurrence after BCG immunotherapy, respectively. The study suggests that cytokine gene variants may modulate CaB susceptibility and risk of recurrence after BCG immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据